Pharmacovigilance – News and Features
News
Introgen Awarded Patent for Gene-Based Therapies Combined with Conventional Therapies
Patent covers any therapeutic gene in combination with radiation and chemotherapy.
News
BioXell and Lay Line Announce License Agreement
Both Companies have announced license agreement for the development of a humanized monoclonal antibody 'MNAC13'.
News
Ciphergen and Sanofi-Aventis Announces Pharmaceutical Biomarker Research Collaboration
Research to concentrate on biomarkers for a pre-clinical drug efficacy study in the field of oncology.
News
Scientists Discover way to fix Drugs with DNA
This is thought to be a crucial step forward for researchers who are developing drugs to combat cancer and other diseases.
News
Pharsight Builds Momentum in DMX® Product, Signs deCODE Genetics
Biopharmaceutical Company selects Drug Model Explorer™ for model-based product profile visualization.
News
Biodesign and TGen form Joint Center for Systems and Computational Biology
This collaboration leverages the growing field of computational biology to speed research and directly impact patients.
News
RxP and BioTrove Announce Collaboration
The Companies will provide primate-human transcription and SNP assays for toxicology.
News
Nanomedicine Center to Help Develop Cancer and CNS Therapies
The University of Maryland and Rexahn Pharmaceuticals are working together to help develop cancer-fighting drugs and central nervous system therapies.
News
LabCorp® Licenses the Seryx Pharmacogenetic Interpretation and Reporting Service
Proprietary service helps physicians use CYP450 information to customize medications for optimal patient treatment.
News
Tool developed to Silence Genes in Specific Tissues Using RNAi
Investigators have developed a way to use the RNAi approach to silence a selected gene.
Advertisement
